The impact of immunomodulatory treatment on kappa free light chains as biomarker in neuroinflammation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cells ; 9 (2020), 4. - Art.-Nr. 842. - eISSN 2073-4409
- Schlagwort
-
Multiple Sklerose
Liquor cerebrospinalis
Biomarker
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2020
- Urheber
-
Konen, Franz Felix
Wurster, Ulrich
Witte, Torsten
Jendretzky, Konstantin Fritz
Gingele, Stefan
Tumani, Hayrettin
Sühs, Kurt-Wolfram
Stangel, Martin
Schwenkenbecher, Philipp
Skripuletz, Thomas
- DOI
-
10.18725/OPARU-42283
- URN
-
urn:nbn:de:bsz:289-oparu-42359-1
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Konen, Franz Felix
- Wurster, Ulrich
- Witte, Torsten
- Jendretzky, Konstantin Fritz
- Gingele, Stefan
- Tumani, Hayrettin
- Sühs, Kurt-Wolfram
- Stangel, Martin
- Schwenkenbecher, Philipp
- Skripuletz, Thomas
- Universität Ulm
Entstanden
- 2020
Ähnliche Objekte (12)
ZNS-Proteine im Liquor : welche Faktoren beeinflussen ihre Konzentration und was ist ihre klinische Relevanz?
Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Analyse des klinischen Verlaufs und der differentiellen Genexpression Interferon-beta-1a therapierter Patienten mit Multipler Sklerose
Longitudinal serum neurofilament levels of multiple sclerosis patients before and after treatment with first-line immunomodulatory therapies
The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
Automated analysis of cerebrospinal fluid cells using commercially available blood cell analysis devices—a critical appraisal
Neurological manifestation of HEV infection: still a rare disease entity?
Neurological manifestation of HEV infection: still a rare disease entity?
Safety and tolerability of plasma exchange and immunoadsorption in neuroinflammatory diseases
The special role of CXCL13 in Lyme neuroborreliosis: a case report
ZNS-Proteine im Liquor : welche Faktoren beeinflussen ihre Konzentration und was ist ihre klinische Relevanz?
Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Analyse des klinischen Verlaufs und der differentiellen Genexpression Interferon-beta-1a therapierter Patienten mit Multipler Sklerose
Longitudinal serum neurofilament levels of multiple sclerosis patients before and after treatment with first-line immunomodulatory therapies
The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
Automated analysis of cerebrospinal fluid cells using commercially available blood cell analysis devices—a critical appraisal
Neurological manifestation of HEV infection: still a rare disease entity?
Neurological manifestation of HEV infection: still a rare disease entity?
Safety and tolerability of plasma exchange and immunoadsorption in neuroinflammatory diseases
The special role of CXCL13 in Lyme neuroborreliosis: a case report
ZNS-Proteine im Liquor : welche Faktoren beeinflussen ihre Konzentration und was ist ihre klinische Relevanz?
Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Analyse des klinischen Verlaufs und der differentiellen Genexpression Interferon-beta-1a therapierter Patienten mit Multipler Sklerose
Longitudinal serum neurofilament levels of multiple sclerosis patients before and after treatment with first-line immunomodulatory therapies
The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
Automated analysis of cerebrospinal fluid cells using commercially available blood cell analysis devices—a critical appraisal
Neurological manifestation of HEV infection: still a rare disease entity?
Neurological manifestation of HEV infection: still a rare disease entity?
Safety and tolerability of plasma exchange and immunoadsorption in neuroinflammatory diseases